Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors von Soria, J.-C., DeBraud, F., Bahleda, R., Adamo, B., Andre, F., Dientsmann, R., Delmonte, A., Cereda, R., Isaacson, J., Litten, J., Allen, A., Dubois, F., Saba, C., Robert, R., D'Incalci, M., Zucchetti, M., Camboni, M.G., Tabernero, J.

Volltext

Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver von Pusceddu, Sara, Citterio, Davide, Facciorusso, Antonio, Coppa, Jorgelina, Milione, Massimo, Buzzoni, Roberto, Bongini, Marco, de Braud, Filippo, Mazzaferro, Vincenzo

Volltext

Corrections to “Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors” von Soria, J.-C., DeBraud, F., Bahleda, R., Adamo, B., Andre, F., Dienstmann, R., Delmonte, A., Cereda, R., Isaacson, J., Litten, J., Allen, A., Dubois, F., Saba, C., Robert, R., D'Incalci, M., Zucchetti, M., Camboni, M.G., Tabernero, J.

Volltext

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer von CASSIDY, Jim, TABERNERO, Josep, SCHÖFFSKI, Patrick, SOBRERO, Alberto, VAN CUTSEM, Eric, DIAZ-RUBIO, Eduardo, TWELVES, Chris, BRUNET, René, BUTTS, Charles, CONROY, Thierry, DEBRAUD, Filippo, FIGER, Arie, GROSSMANN, Johannes, SAWADA, Noriaki

Volltext

Improved efficacy response attributed to diagnostic selection – Interim results of the phase 1 experience from ALKA-372-001 von Christiansen, J., Siena, S., Valtorta, E., Johnson, A., Murphy, D., Shoemaker, R., Lamoureux, J., Luo, D., Patel, R., Hornby, Z., Multani, P., Maneval, E. Chow, Duca, M., Debraud, F.

Volltext

6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study von Bokemeyer, C, Bondarenko, I, Hartmann, J.T, DeBraud, F, Schuch, G, Zubel, A, Celik, I, Koralewski, P

Volltext

The biological basis for antiangiogenic therapy von Giavazzi, R, Albini, A, Bussolino, F, DeBraud, F, Presta, M, Ziche, M, Costa, A

Volltext

Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil von DEBRAUD, F, MUNZONE, E, NOLE, F, DE PAS, T, BIFFI, R, BRIENZA, S, AAPRO, M. S

Volltext

Phase I/II study of the tumor-targeting human L19-IL2 monoclonal antibody-cytokine fusion protein in combination with DTIC in metastatic melanoma patients von Garbe, C., Romanini, A., Spitaleri, G., Giovannoni, L., Zardi, L., Neri, D., Shaw, A., Menssen, H. D., deBraud, F., Eigentler, T. K.

Volltext

Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours : Experience from 178 cases using a single type of dev... von BIFFI, R, CORRADO, F, ANDREONI, B, DE BRAUD, F, DE LUCIA, F, SCARPA, D, TESTORI, A, ORSI, F, BELLOMI, M, MAURI, S, AAPRO, M

Volltext

Intrapericardial treatment of neoplastic pericardial effusions von Martinoni, A, Cipolla, C M, Civelli, M, Cardinale, D, Lamantia, G, Colleoni, M, DeBraud, F, Susini, G, Martinelli, G, Goldhirsh, A, Fiorentini, C

Volltext

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis von Janot, F, Klijanienko, J, Russo, A, Mamet, J P, de Braud, F, El-Naggar, A K, Pignon, J P, Luboinski, B, Cvitkovic, E

Volltext

Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic bu... von Nolè, F., de Braud, F., Aapro, M., Minchella, I., De Pas, M., Zampino, M. G., Monti, S., Andreoni, G., Goldhirsch, A.

Volltext

Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas von Klijanienko, Jerzy, De Braud, Filippo, Russo, Anna, Janot, François, Luboinski, Bernard, Cvitkovic, Esteban, El‐Naggar, Adel K., Rodriguez‐Peralto, José‐Louis, Rodriguez, Rosario, Itzhaki, Moshé

Volltext

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international... von Twelves, C., Butts, C., Cassidy, J., Conroy, Th, DeBraud, F., Díaz-Rubio, E., Figer, A., Grossmann, J., Schoffski, P., Tabernero, J., Sobrero, A., Van Cutsem, E.

Volltext

Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment von de Braud, F., Heilbrun, L. K., Ahmed, K., Sakr, W., Ensley, J. F., Kish, J. A., Tapazoglou, E., Al‐Sarraf, M.

Volltext

Supplementary Material for: Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram von Pietrantonio, F., Barretta, F., Fanotto, V., Park, S.H., Morano, F., Fucà, G., Niger, M., Prisciandaro, M., Silvestris, N., Bergamo, F., Fornaro, L., Bordonaro, R., Rimassa, L., Santini, D., Tomasello, G., Antonuzzo, L., Noventa, S., Avallone, A., Leone, F., Faloppi, L., DiDonato, S., DeBraud, F., Lee, J., DeVita, F., DiBartolomeo, M., Miceli, R., Aprile, G.

Volltext bestellen

Characterization of the response of human thymocytes and blood lymphocytes to the synergistic mitogenicity of 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) ionomycin von Delia, Domenico, Greaves, Melvyn, Villa, Silvia, Debraud, Filippo

Volltext

Treatment of Carcinoid Syndrome with Recombinant Interferon Alpha-2a von Di Bartolomeo, Maria, Bajetta, Emilio, Zilembo, Nicoletta, de Braud, Filippo, Di Leo, Angelo, Verusio, Claudio, D'aprile, Modesto, Scanni, Alberto, Iirillo, Antonio, Barduagni, Aldo, Epifani, Cosimo

Volltext

Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma von Buzzoni, R., Colleoni, M., Bajetta, E., Nolè, F., Nelli, P., De Palma, C. A., de Braud, F.

Volltext